U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082881) titled 'Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants' on July 05.
Brief Summary: The goal of this clinical trial is to ascertain whether oropharyngeal administration of colostrum contributes to postnatal growth in very preterm infants (those born before 32 weeks of gestation). The main questions it aims to answer are:
Can Oropharyngeal administration of colostrum effectively lower the incidence rate of extrauterine growth restriction (EUGR) in participants? Does oropharyngeal colostrum intervention bring about changes in the early gut microbiota of participants? Researchers will conduct a comparati...